In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it
However, when patients stopped taking Tesamorelin, the fat reduction benefits were quickly reversed, suggesting that continued use is necessary to maintain results
Give your body the care it craves and unlock your ultimate potentialbecause you deserve to feel and look amazing
Both stimulate your own pituitary to release growth hormone
We operate two factories covering a total construction area of 23000 square metre
In practical terms, this translates to measurable results